Gloyn, A., Diatloff-Zito, C., Edghill, E., Bellanné-Chantelot, C., Nivot, S., Coutant, R., . . . Robert, J. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
Chicago Style (17th ed.) CitationGloyn, A., C. Diatloff-Zito, E. Edghill, C. Bellanné-Chantelot, S. Nivot, R. Coutant, S. Ellard, A. Hattersley, and J. Robert. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.
MLA引文Gloyn, A., et al. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.
警告:這些引文格式不一定是100%准確.